A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Biological Activity, and PK of ND L02 s0201 in Subjects with Idiopathic Pulmonary Fibrosis (IPF)

Project: Research project

Description

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Biological Activity, and PK of ND L02 s0201 in Subjects with Idiopathic Pulmonary Fibrosis (IPF)
StatusActive
Effective start/end date10/2/181/1/21

Funding

  • NITTO DENKO TECH CORP

Fingerprint

Idiopathic Pulmonary Fibrosis
Placebos
Safety